Evidence map›Paper›PMID 35696457›Full record

ArticleCirculation2022

At the Crossroad Between Skeletal and Cardiac Muscle Cells.

Christopher R deFilippi, Abdulla A Damluji

Abstract readEditorialComment
In one paragraph

Article in Circulation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Christopher R deFilippiFrom the Inova Heart and Vascular Institute, Falls Church, VA (C.R.d.F., A.A.D.).
Abdulla A DamlujiFrom the Inova Heart and Vascular Institute, Falls Church, VA (C.R.d.F., A.A.D.).ORCID 0000-0002-8774-6416

Funding

Technological Assessment and Solutions Core - RC4P30AG021334 · NIA · JOHNS HOPKINS UNIVERSITY · PI Jeremy D Walston · 2003 to 2026
$33.2M
The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve HealthUL1TR003015 · NCATS · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, JOHNSTON, KAREN C. · 2019 to 2023
$20.3M
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWHR01HL151293 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SRINIVASA, SUMAN · 2020 to 2024
$4.2M
The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalizationR01HL154768 · NHLBI · INOVA HEALTH CARE SERVICES · PI COOPER, LAUREN BETH, DEFILIPPI, CHRISTOPHER R · 2020 to 2023
$1.6M
Frailty and Resiliency in Older Adults with Acute Myocardial InfarctionK23HL153771 · NHLBI · INOVA HEALTH CARE SERVICES · PI DAMLUJI, ABDULLA AL · 2020 to 2024
$916k
Clonal hematopoiesis and severity of COVID-19 diseaseR21AG072095 · NIA · UNIVERSITY OF VIRGINIA · PI DEFILIPPI, CHRISTOPHER R, WALSH, KENNETH · 2021 to 2022
$457k
NCATS NIH HHS UL1 TR003015NHLBI NIH HHS K23 HL153771NHLBI NIH HHS R01 HL151293NHLBI NIH HHS R01 HL154768NIA NIH HHS P30 AG021334NIA NIH HHS R21 AG072095
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myocytes, CardiacTroponinHumansMuscle, SkeletalMyocardiumTroponin TTroponinTroponin TbiomarkersEditorialsmuscle, skeletalmyocardiumtroponin

Identifiers

PMID35696457
PMCPMC9202001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.